Løndalen, Ayca
Blakkisrud, Johan
Revheim, Mona-Elisabeth
Madsbu, Ulf Erik
Dahle, Jostein
Kolstad, Arne
Stokke, Caroline
Funding for this research was provided by:
Helse Sør-Øst RHF
Nordic Nanovector ASA
Article History
Received: 2 September 2020
Accepted: 26 October 2020
First Online: 16 November 2020
Compliance with ethical standards
:
: Arne Kolstad were both in part supported by grants from the Norwegian Cancer Society. Arne Kolstad is member of the Scientific Advisory Board of Nordic Nanovector ASA. Jostein Dahle is an employee and shareholder of Nordic Nanovector ASA. Ayca Løndalen has no conflict of interest. Johan Blakkisrud has no conflict of interest. Mona-Elisabeth Revheim has no conflict of interest. Ulf Erik Madsbu has no conflict of interest. Caroline Stokke has no conflict of interest.
: All procedures performed were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.